← FDA Drug Approvals (Drugs@FDA)

INLYTA

NDA · New Drug Application · Sponsor: PF PRISM CV · Approved 2012-01-27

Drug application

FDA Application #

NDA202324

Application type

New Drug Application

Brand name

INLYTA

Generic name

AXITINIB

Active ingredients

AXITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PF PRISM CV

Manufacturer

U.S. Pharmaceuticals

First approval

2012-01-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown